Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study

Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study

Background: The J-Land 3S trial demonstrated that landiolol is effective and tolerated for treating sepsis-related tachyarrhythmias. Patient characteristics (e.g. baseline heart rate [HR], type of tachyarrhythmia, and concomitant disorders) may impact the outcomes of landiolol therapy. We performed...

Full description

Bibliographic Details
Main Authors: Naoyuki Matsuda, Osamu Nishida, Takumi Taniguchi, Masaki Okajima, Hiroshi Morimatsu, Hiroshi Ogura, Yoshitsugu Yamada, Tetsuji Nagano, Akira Ichikawa, Yasuyuki Kakihana
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:EClinicalMedicine
Subjects:
Ultra-short-acting β1-selective antagonist
Heart rate
Mortality
Adverse events
Septic shock
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020303151

Internet

http://www.sciencedirect.com/science/article/pii/S2589537020303151

Similar Items